The medical affairs industry is a growing sector of pharmaceutics and encompasses a number of different businesses and operations. This includes providing product safety information for healthcare professionals, raising awareness on new treatment ideas, and managing key thought leader relationships. The industry is expected to reach a size of $2.65bn by 2026
Surveying the global market to unlock key insights for due diligence
proSapient supported a European Private Equity firm to research and ultimately purchase a majority stake at a European medical affairs consultancy.
How proSapient helped
proSapient supported our client to design, build and field a survey of 100 medical affairs and market access professionals in Europe and the US. proSapient also identified and facilitated expert calls with executives in the space to bring qualitative insights to the study.
The historical spend on digital solutions in medical market access
Understanding the extent of near-term and long-term implications on medical affairs budgets as a result of COVID-19
The expected impact on drug launches and development plans due to COVID-19
Identifying key growth opportunities for service providers to expand their fee income post-COVID-19
Assessing tolerance for changes in pricing structure for medical agencies post-COVID-19
I’m very pleased with how the survey worked. I think it’s a great tool that we will use again in the future.
proSapient’s survey platform and service supported a successful acquisition decision, as well as a partnership that will facilitate global healthcare customer insights and patient engagement.
More case studies
Dentistry chain acquisition
The European dental industry is worth over $70bn, with stable revenue growth, fragmented players and margins between 20-40%.
proSapient in private equity
Karim Id Boufker discussed his experiences working with proSapient